Objective: The article examines the objective, findings, and clinical context described in FDA approves HPV immunotherapy for RRP. Approach: Approval: The FDA g

Objective: Reflect on the author’s ASCP presidency, organizational priorities, and upcoming transition at the next Annual Meeting. Approach: Presidential year:

Objective: Introduce an upcoming ASCP 2026 educational session on conditions that can resemble inflammatory bowel disease (IBD). Approach: Presenters: Ilke Nalb

Objective: To assess whether whole-genome sequencing of circulating tumor DNA can detect residual disease and predict recurrence after surgery for stage IA lung

Objective: Franchina describes his research focus, views on analytical science, and experiences that have shaped his career. Approach: Research focus: He develo

Objective: The article examines the objective, findings, and clinical context described in What Will It Take to Control Continuous Biomanufacturing?. Approach:

Objective: To report initial safety, B-cell depletion, and disability outcomes with azer-cel in people with progressive multiple sclerosis. Approach: Study: The

Objective: The article examines CEACAM5 and CEACAM6 as potential lung cancer risk biomarkers in people who never smoked and discusses the need for risk-based sc

Objective: Assess how to interpret Comtois et al.’s trial of Caring Contacts among American Indian and Alaska Native adults at elevated suicide risk. Approach:

Objective: To notify readers that Tables 1 and 2 in the original article were published incorrectly and have since been corrected. Approach: Correction: The not

Objective: The article examines the objective, findings, and clinical context described in Redefining ARDS for Global Reach and Personalized Care: Part 2. Appro

Objective: To report the Editor’s concern that the authors have not responded to requests seeking access to their datasets or to Publisher correspondence regard